---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-034907"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:51:20.890258+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Received Nasdaq staff determination to delist due to failure to maintain $1.00 minimum bid price.
- Company plans to request a hearing before Nasdaq Hearings Panel to appeal the delisting determination.
- Company is evaluating alternatives to regain compliance; no assurance of success.
- If delisted, securities expected to trade on OTC Markets platform.
- Company previously under mandatory Panel Monitor, making it ineligible for standard compliance period.

## SEC filing metadata
- accession: 0001493152-23-034907
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315223034907/0001493152-23-034907-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315223034907/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-034907
- JSON: https://secwatch.observer/filing/0001493152-23-034907.json
- Plain text: https://secwatch.observer/filing/0001493152-23-034907.txt

## Key facts
- Listing & Compliance Notices
  Bone Biologics Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: September 27, 2023, Bone Biologics Corporation (the “Company”) received a written notice (the “Notice”) from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it failed to comply with the $1.00 per share minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). As a result of the imposition of a mandatory Panel Monitor, as previously disclosed on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on May 19, 2023, the Company is not eligible for a compliance period to regain compliance with the minimum bid price requirement. Acco
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223034907/0001493152-23-034907-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.